Allspring Global Investments’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$94.9M Buy
441,647
+2,169
+0.5% +$481K 0.16% 150
2025
Q4
$101M Sell
439,478
-171,116
-28% -$39M 0.16% 154
2025
Q3
$149M Buy
610,594
+93,560
+18% +$19.1M 0.24% 107
2025
Q2
$98.2M Sell
517,034
-113,867
-18% -$21.2M 0.16% 153
2025
Q1
$130M Sell
630,901
-5,803
-0.9% -$1.13M 0.23% 110
2024
Q4
$114M Buy
636,704
+182,962
+40% +$33.6M 0.18% 128
2024
Q3
$89.6M Sell
453,742
-65,802
-13% -$12.3M 0.14% 174
2024
Q2
$89.1M Buy
519,544
+8,679
+2% +$1.44M 0.15% 166
2024
Q1
$93M Buy
510,865
+5,567
+1% +$959K 0.15% 165
2023
Q4
$78.3M Buy
505,298
+108,484
+27% +$15.8M 0.13% 192
2023
Q3
$59.1M Buy
396,814
+19,814
+5% +$2.91M 0.11% 246
2023
Q2
$50.8M Sell
377,000
-233,365
-38% -$34.2M 0.08% 318
2023
Q1
$97.3M Sell
610,365
-150,223
-20% -$23M 0.16% 149
2022
Q4
$123M Sell
760,588
-341,456
-31% -$52.4M 0.21% 117
2022
Q3
$148M Sell
1,102,044
-236,261
-18% -$33.9M 0.26% 77
2022
Q2
$205M Sell
1,338,305
-394,641
-23% -$60.3M 0.34% 53
2022
Q1
$281M Sell
1,732,946
-282,335
-14% -$41M 0.35% 45
2021
Q4
$273M Buy
+2,015,281
New +$238M 0.3% 60

Other funds holding ABBV

Allspring Global Investments's ABBV Position: Q1 2026 in Review

Allspring Global Investments increased its AbbVie (ABBV) stake by 0.49% in Q1 2026, buying an estimated $481K and bringing the position to 441,647 shares worth $94.9M. The position accounts for 0.16% of the portfolio, ranked #150.

Allspring Global Investments first reported a position in ABBV in Q4 2021 and has held it in 18 quarters since. The position peaked at $281M in Q1 2022. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Allspring Global Investments held 441,647 shares of AbbVie worth $94.9M as of Q1 2026.
  • Allspring Global Investments bought 2,169 AbbVie shares in Q1 2026, an estimated $481K.
  • AbbVie made up 0.16% of Allspring Global Investments's portfolio in Q1 2026, its #150 holding.
  • Allspring Global Investments first reported a position in AbbVie in Q4 2021 and has held it in 18 quarters since.
  • Allspring Global Investments's AbbVie position peaked at $281M in Q1 2022.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Allspring Global Investments's 13F filing for Q1 2026, filed 5 May 2026.